Trovagene Trovagene Enters Deal With Novogene for NextCollect in China Novogene will validate Trovagene's proprietary urine collection and nucleic acid preservation device, NextCollect, and develop tests for the Chinese market. Trovagene Inks Cancer Biomarker Deal With AstraZeneca AstraZeneca will use Trovagene's Trovera EGFR urine liquid biopsy test in an open-label prospective biomarker study. Trovagene Q4 Revenues Down, Company Restructuring to Expand Into Therapeutics The firm announced a 14 percent drop year-over-year in fourth quarter revenues and plans to reduce personnel and other costs to support development of a precision drug it has licensed. Trovagene Signs Deals to Distribute Liquid Biopsy Tests in Europe, Middle East The distributors will promote Trovagene's clinical test services, and will also gain access to the research-use kits the firm is co-developing with Boreal Genomics. Trovagene Reorganizes After Boreal Deal, Cuts 20 Jobs The company believes that the reduction in staff and marketing costs for its testing services will reduce its annual pre-tax expenses by about $4 million. Nov 30, 2016 Trovagene, Boreal Genomics to Co-Develop Kits for ctDNA Analysis Nov 9, 2016 Trovagene Q3 Revenues Climb 56 Percent Oct 4, 2016 Pancreatic Cancer Action Network Unveils Precision Medicine Clinical Trial Aug 17, 2016 BCBS Illinois to Cover Trovagene Liquid Biopsy Tests Aug 4, 2016 Trovagene Q2 Revenues Grow But Miss Estimates Jul 29, 2016 Trovagene's Dual-Sample Liquid Biopsy Performs Well in First Peer-Reviewed Study Premium Jul 12, 2016 Trovagene, USC Collaborate on Deployment of Urine-Based Liquid Biopsy Test Jul 6, 2016 Trovagene, University of Michigan to Collaborate on Pancreatic Cancer Monitoring, Early Detection May 10, 2016 Trovagene Q1 Revenues Fall 6 Percent as Net Loss Swells Mar 29, 2016 Trovagene Terminates CEO Schuh and CFO Zaniboni for Breach of Duty Mar 10, 2016 Trovagene Q4 Revenues up 41 Percent as Net Loss Widens Feb 1, 2016 Trovagene Inks Deal to Provide Liquid Biopsies Through PPO FedMed Jan 21, 2016 Trovagene to Offer Liquid Biopsy Through America's Choice Provider Network Nov 9, 2015 Trovagene Reports Flat Q3 Revenues; Halves Net Loss Sep 16, 2015 Cantor Fitzgerald Starts Coverage of Trovagene With Buy Rating Sep 10, 2015 Trovagene Forms European Institute Headed by U Torino Researcher Alberto Bardelli Aug 14, 2015 Leerink Initiates Coverage of Trovagene with Outperform Rating Aug 10, 2015 Trovagene's Q2 Net Loss Swells 10-Fold on Increased Operating Expenses Jul 22, 2015 Trovagene Raises $40M in Public Offering of Shares Jul 17, 2015 Trovagene Prices $35M Stock Offering Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.